Xavier Keutgen, MD

National Institutes of Health
Fellowship

University of Zurich
Fellowship

New York Presbyterian Hospital
Residency

New York Presbyterian Hospital
Internship

University of Heidelberg Medical School
MD

The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors.
The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2025 May 03.
PMID: 40319207

Treatment at Academic Facilities is Associated With Improved Survival in Late-Stage Colonic Neuroendocrine Tumors.
Treatment at Academic Facilities is Associated With Improved Survival in Late-Stage Colonic Neuroendocrine Tumors. J Surg Res. 2025 Apr 24; 310:111-121.
PMID: 40279914

Prevalence and Clinical Impact of BRAF p.V600E Mutation in Papillary Thyroid Carcinoma.
Prevalence and Clinical Impact of BRAF p.V600E Mutation in Papillary Thyroid Carcinoma. Endocr Pathol. 2025 Apr 16; 36(1):13.
PMID: 40237893

Multi-institutional development and testing of attention-enhanced deep learning segmentation of thyroid nodules on ultrasound.
Multi-institutional development and testing of attention-enhanced deep learning segmentation of thyroid nodules on ultrasound. Int J Comput Assist Radiol Surg. 2025 Feb; 20(2):259-267.
PMID: 39751996

Developing a Predictive Model for Metastatic Potential in Pancreatic Neuroendocrine Tumor.
Developing a Predictive Model for Metastatic Potential in Pancreatic Neuroendocrine Tumor. J Clin Endocrinol Metab. 2024 Dec 18; 110(1):263-274.
PMID: 38817124

Adolescent Hyperparathyroidism: An Updated Contemporary Surgical Experience at a Tertiary Center.
Adolescent Hyperparathyroidism: An Updated Contemporary Surgical Experience at a Tertiary Center. J Surg Res. 2025 Jan; 305:150-155.
PMID: 39693848

Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence.
Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence. J Clin Endocrinol Metab. 2024 Oct 15; 109(11):2729-2734.
PMID: 38651609

Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study.
Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study. Surgery. 2025 01; 177:108833.
PMID: 39394019

Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors.
Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2025 01; 177:108834.
PMID: 39395860

MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
PMID: 39093924